TracePack introduces new 88S CIJ Security System
Issued by TracePack - Jul 4th, 14:28
Print Invisible, UV Light Readable. Product Security and Counterfeit Avoidance.
TracePack’s Model 88S Security is targeted at product traceability, security, counterfeit avoidance and brand protection applications. Ensure the product in question is truly your product.
Print real-time One-Dimensional (1D) and Two-Dimensional (2D) barcodes— Datamatrix, QR Code and other custom dot codes on demand. Barcodes can be encrypted with company and product specific serialisation information.
Invisible ink prints clear and invisible—can only be seen when fluoresced with UV light. The codes and marks light up a bright blue colour. Printing is permanent to a wide range of substrates—drying immediately on metal, glass, plastic and more.
Invisible codes survive high temperatures and remain invisible when exposed to high temperatures, steam processes such as that used for pasteurisations or sterilisation processes.
Typical applications mark and code one, two or 3 shifts per day or 24/7 operations, five to seven days per week, averaging 4,000 – 8,760-hour annual operation. Utilise integrated RS232 and programmable inputs\outputs for remote control and communications.
Systems are simplified to allow anyone to operate, minimizing operator touches, extending time between human interaction.
Click here for more information on Mitas
One of the most important aspects of the manufacturing process of fast-moving consumer goods (FMCG) in South Africa, is the use of high-quality coding and marking systems to provide full traceability for the manufacturer and authentic information for the end user.
The counterfeiting of pharmaceutical products is an enormous risk for consumers’ health and a major economic loss for the pharmaceutical industry. The safety of pharmaceutical products is a necessity for the final consumer and it requires an utmost control of the flow of products, from the manufacturing to the distribution.
Counterfeit pharmaceuticals are a major problem for the proprietary pharmaceutical industry causing loss of revenues, damage reputations, and pose significant health risks to consumers, with the WHO estimating one million people die every year from counterfeit drugs. They also pose indirect costs to society as counterfeiting often supports organised crime.
At the recent Tax Stamp Forum™, we were happy to welcome Kyle Parker, Group CEO of MITAS Corporation, who spoke about the group’s 28-year journey from its original activity of producing human-readable product markers, to being ‘pulled in the direction’ of brand protection, authentication and track and trace.